Contributors
Numbers in parentheses indicate the pages on which the authors’ contributions begin.
Jay A. Berzofsky
, Vaccine Branch, Center for Cancer Research, NationalCancer Institute, National Institutes of Health, Bethesda, Maryland, USA(277)
Martin Cadogan
, Laboratory of Oncology, Department of Cellular andMolecular Medicine, St George’s University of London, London, UnitedKingdom (349)
Ashok K. Chakraborty
, Department of Dermatology and the Yale CancerCenter, Yale University School of Medicine, New Haven, Connecticut,USA (397)
Steven Y. Cheng
, Center for Cancer Research, Nanjing Medical University,Nanjing, Jiangsu, PR China (29)
Kimberly L. Christensen
, Program in Molecular Biology, University of Colorado School of Medicine, Denver, Colorado, USA (93)
Orly Cohen
, The Lautenberg Center for General and Tumor Immunology,The Institute of Medical Research, The Hebrew University, HadassahMedical School, Jerusalem, Israel (127)
Angus G. Dalgleish
, Laboratory of Oncology, Department of Cellular andMolecular Medicine, St George’s University of London, London, UnitedKingdom (349)
Heide L. Ford
, Department of Biochemistry and Molecular Genetics,University of Colorado School of Medicine, Denver, Colorado andDepartment of Obstetrics and Gynecology, University of Colorado Schoolof Medicine, Denver, Colorado, and Program in Molecular Biology,University of Colorado School of Medicine, Denver, Colorado, USA (93)
Federico Garrido
, Department of Analisis Clinicos e Inmunologia; HospitalUniversitario Virgen de las Nieves; Universidad de Granada, Granada,Spain (249)
Vi Luan Ha
, Laboratory of Cellular and Molecular Biology, NationalCancer Institute, Bethesda, Maryland, USA (1)
Zi-ChunHua
,StateKeyLaboratoryofPharmaceuticalBiotechnology,Collegeof Life Science, Nanjing University, Nanjing, PR China (45)
ix
Add a Comment